These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2138049

  • 21. Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II-converting enzyme inhibitors.
    Menezes Ada S, Moreira HG, Daher MT.
    Arq Bras Cardiol; 2004 Aug; 83(2):169-72; 165-8. PubMed ID: 15322659
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the effects of felodipine and cilazapril on exercise performance in patients with mild to moderate hypertension. A crossover study.
    Paterna S, Di Pasquale P, Parrinello G, Tuttolomondo A, Follone G, Cardinale A, Ortoleva A, Giambanco F, Abruzzese G, Colomba D, Bologna P, Fernández P, Giubilato A, Valdes L, Albano V, Licata G.
    Drugs Exp Clin Res; 2000 Aug; 26(4):125-31. PubMed ID: 11109512
    [Abstract] [Full Text] [Related]

  • 23. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group.
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [Abstract] [Full Text] [Related]

  • 24. Comparative evaluation of the acute and chronic effects of cilazapril and hydrochlorothiazide on diastolic cardiac function in hypertensive patients.
    Schneeweiss A, Rosenthal J, Marmor A.
    J Hum Hypertens; 1990 Oct; 4(5):535-9. PubMed ID: 2149388
    [Abstract] [Full Text] [Related]

  • 25. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD, Binstok G, Mullane JF, Woods JW, Pittman AW, del Greco F, Huang C, Morledge JH.
    Clin Ther; 1983 Oct; 5(5):525-39. PubMed ID: 6352036
    [Abstract] [Full Text] [Related]

  • 26. Impact of cilazapril on fibrinolytic system in hypertensive patients.
    Hosgor I, Ahmad S.
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):101-5. PubMed ID: 18180626
    [Abstract] [Full Text] [Related]

  • 27. [Cilazapril, a new ACE inhibitor, in severe arterial hypertension].
    Arcila Herrera H, Montero Cervantes L, Rivero Cárdenas NA, Osorio Guerreo MI, Flores Serrano AG, González Franco MF.
    Arch Inst Cardiol Mex; 1991 Jan; 61(6):573-8. PubMed ID: 1838916
    [Abstract] [Full Text] [Related]

  • 28. Twenty-four-hour blood pressure control: effect of cilazapril on continuous arterial blood pressure during sleep, and physical and mental load in patients with arterial hypertension and sleep apnea.
    Grote L, Heitmann J, Schneider H, Ploch T, Penzel T, Peter JH, von Wichert P.
    J Cardiovasc Pharmacol; 1994 Jan; 24 Suppl 3():S78-82. PubMed ID: 7700072
    [Abstract] [Full Text] [Related]

  • 29. Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients.
    Ding YA, Law HW, Chou TC.
    J Hum Hypertens; 1994 Feb; 8(2):137-43. PubMed ID: 8207740
    [Abstract] [Full Text] [Related]

  • 30. The effect of the year angiotensin-converting enzyme inhibitors (ACE I) intake on circadian heart rate variability in patients with primary hypertension.
    Banach T, Kolasińska-Kloch W, Furgała A, Laskiewicz J.
    Folia Med Cracov; 2001 Feb; 42(3):129-40. PubMed ID: 12353420
    [Abstract] [Full Text] [Related]

  • 31. Review of studies on the clinical pharmacodynamics of cilazapril.
    Belz GG, Breithaupt K, Erb K.
    J Cardiovasc Pharmacol; 1994 Feb; 24 Suppl 2():S14-9. PubMed ID: 7898090
    [Abstract] [Full Text] [Related]

  • 32. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH, Erb K, Essig J, Breithaupt K, Belz GG.
    Br J Clin Pharmacol; 1989 Feb; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [Abstract] [Full Text] [Related]

  • 33. The effect of cilazapril on systolic and diastolic cardiac function in hypertensive patients.
    Schneeweiss A, Green T, Krakuer J, Goldhamer E, Szucs T, Marmor A.
    J Hum Hypertens; 1989 Aug; 3(4):251-4. PubMed ID: 2529375
    [Abstract] [Full Text] [Related]

  • 34. Dose-finding study of cilazapril (Inhibace) in patients with uncomplicated essential hypertension.
    Mroczek WJ, Klein J, Burris JF.
    Clin Exp Hypertens A; 1991 Aug; 13(8):1415-32. PubMed ID: 1836986
    [Abstract] [Full Text] [Related]

  • 35. Long-term evaluation of cilazapril in severe hypertension. Assessment of left ventricular and renal function.
    Sánchez RA, Traballi CA, Marcó EJ, Cianciulli T, Giannone CA, Ramiréz AJ.
    Am J Med; 1989 Dec 26; 87(6B):56S-60S. PubMed ID: 2532462
    [Abstract] [Full Text] [Related]

  • 36. The effect of cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patients.
    Güntzel P, Kobrin I, Pasquier C, Zimlichman R, Viskoper JR.
    J Cardiovasc Pharmacol; 1991 Jan 26; 17(1):8-12. PubMed ID: 1708060
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients.
    Belz GG, Essig J, Erb K, Breithaupt K, Hoogkamer JF, Kneer J, Kleinbloesem CH.
    Br J Clin Pharmacol; 1989 Jan 26; 27 Suppl 2(Suppl 2):317S-322S. PubMed ID: 2527545
    [Abstract] [Full Text] [Related]

  • 38. Comparative effects of 2.5 and 5 mg cilazapril versus placebo on daily blood pressure load.
    Poirier L, Pyzyk M, Provencher P, Lacourcière Y.
    Am J Hypertens; 1991 Nov 26; 4(11):913-5. PubMed ID: 1838693
    [Abstract] [Full Text] [Related]

  • 39. The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril.
    Kirch W, Stroemer K, Hoogkamer JF, Kleinbloesem CH.
    Br J Clin Pharmacol; 1989 Nov 26; 27 Suppl 2(Suppl 2):297S-301S. PubMed ID: 2527542
    [Abstract] [Full Text] [Related]

  • 40. Vascular protection with cilazapril in hypertension.
    Clozel JP, Kuhn H, Hefti F.
    J Cardiovasc Pharmacol; 1992 Nov 26; 19 Suppl 5():S28-33. PubMed ID: 1381792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.